跳至主要内容
临床试验/NL-OMON49144
NL-OMON49144已完成不适用

Amyloid PET in patients with carotid occlusive disease - AMYCODE

niversitair Medisch Centrum Utrecht0 个研究点目标入组 21 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
21

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study, a patient must meet all
  • of the following criteria:
  • - At least 55 years of age;
  • - Occlusion of the internal carotid artery (ICA) as visible on MR or CT
  • angiography, or DSA;
  • - Mini-mental state examination (MMSE) is higher or equal to 18;
  • - Patients must, in the opinion of the principal investigator/attending
  • neurologist, be able to tolerate the [18F]Florbetaben PET scan procedures and
  • be competent to make a well in-formed decision to participate in this study;

排除标准

  • A potential patient who meets any of the following criteria will be excluded
  • from participation in this study:
  • - Contralateral stenosis of >70% of the ICA or middle cerebral artery (MCA);
  • - History of vascular reconstructive surgery in the brain;
  • - Has evidence of structural abnormalities such as mass on MRI that is likely
  • to interfere with the clinical presentation and/or interpretation of PET scan;
  • - Has ever participated in an experimental study with an amyloid targeting
  • agent, unless it can be documented that the subject received only placebo
  • during the course of the trial;
  • - Has been injected with a previously administered radiopharmaceutical within 6
  • months terminal half-lives OR when the total yearly radiation exposure exceeds
  • - Has other neurological diagnosis, such as Parkinson*s disease, multiple
  • sclerosis or severe traumatic brain injury, or a major psychiatric disorder;

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验